A protein known for burning fat, hormone-sensitive lipase (HSL), has been found to control fat cell health from inside the nucleus. This discovery challenges previous understandings of obesity and metabolic diseases. Scientists previously believed HSL primarily released stored fat for energy.
Researchers at the Université de Toulouse found HSL operating deep inside the nucleus of fat cells. The nucleus stores deoxyribonucleic acid (DNA) and controls genetic activity. This finding reveals a new function for a protein studied since the 1960s.
The research, published in *Cell Metabolism*, helps explain a long-standing mystery in obesity research. It also opens new avenues for understanding diabetes, heart disease, and other metabolic disorders. Fat cells, or adipocytes, are not merely storage units; they actively regulate the body's energy system.
HSL's role in the nucleus appears to involve regulating mitochondrial activity and the extracellular matrix. Mitochondria generate cellular energy. The extracellular matrix provides structural support for tissues. Problems in these systems are linked to obesity, inflammation, and metabolic disease.
Studies of mice and humans lacking HSL showed they developed lipodystrophy, a condition of dangerous fat tissue loss, instead of obesity. This suggests that HSL's nuclear function is crucial for maintaining healthy fat tissue. The amount of nuclear HSL changes with the body's metabolic state.
This discovery suggests that future therapies for metabolic diseases may focus on restoring fat cell function. They may also protect the biological systems that maintain healthy fat tissue. Understanding how proteins like HSL regulate fat cell health could lead to more targeted treatments.
Related stories
Constipation Drug May Slow Chronic Kidney Disease Progression
A clinical trial found that the common constipation drug lubiprostone may slow the progression of chronic kidney disease by altering gut bacteria and improving mitochondrial function.
New Drug Shows Promise for Obesity and Type 2 Diabetes
A new "Trojan horse" drug for obesity and type two diabetes shows promise in mouse studies, delivering a metabolic enhancer directly to cells for improved weight loss and blood sugar control.
WHO assists cruise ship after suspected hantavirus outbreak, evacuations underway.
In a developing public health situation, a cruise ship experienced a significant medical event, necessitating the evacuation of several individuals presenting s...